Free Trial
→ Gold is soaring. Here’s how to get paid from it (From Investors Alley) (Ad) Free BMRN Stock Alerts

BioMarin Pharmaceutical (BMRN) SEC Filings & 10K Form

BioMarin Pharmaceutical logo
$56.92 +0.73 (+1.29%)
As of 12:25 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Recent BioMarin Pharmaceutical SEC Filings

Export to Excel
DateFilerForm TypeView
07/01/2025
8:18 AM		BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
Form SC TO-T/A
06/17/2025
6:28 AM		BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
Form SC TO-T/A
06/04/2025
3:32 PM		BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
Form SC TO-T/A
06/02/2025
5:25 AM		BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
Form SC TO-T
05/20/2025
4:58 PM		BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
8:58 AM		BioMarin Pharmaceutical (Subject)
Burkhart Erin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/19/2025
4:22 PM		BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
Form SC TO-C
05/16/2025
8:44 PM		BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
Form SC TO-C
05/16/2025
4:16 PM		BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
Form SC TO-C
05/16/2025
6:54 AM		BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2025
6:59 AM		BioMarin Pharmaceutical (Subject)
Form SC TO-C
05/13/2025
10:32 AM		BioMarin Pharmaceutical (Subject)
Capital Research Global Investors (Filed by)
Form SCHEDULE 13G/A
05/02/2025
11:33 AM		BioMarin Pharmaceutical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2025
9:05 AM		BioMarin Pharmaceutical (Subject)
Hubbard Cristin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/29/2025
8:14 AM		BioMarin Pharmaceutical (Subject)
BlackRock, Inc. (Filed by)
Form SCHEDULE 13G/A
04/08/2025
3:09 PM		BioMarin Pharmaceutical (Filer)
Form DEF 14A
04/08/2025
3:12 PM		BioMarin Pharmaceutical (Filer)
Form DEFA14A
03/20/2025
6:38 PM		BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
8:36 AM		BioMarin Pharmaceutical (Subject)
Burkhart Erin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/18/2025
6:51 PM		BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
6:53 PM		BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
5:23 PM		BioMarin Pharmaceutical (Issuer)
Friberg Gregory R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
5:25 PM		BioMarin Pharmaceutical (Issuer)
Hubbard Cristin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
5:17 PM		BioMarin Pharmaceutical (Issuer)
Hardy Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
5:19 PM		BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
5:22 PM		BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
3:11 PM		BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
6:15 PM		BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
6:17 PM		BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
6:19 PM		BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
3:18 PM		BioMarin Pharmaceutical (Issuer)
Walbert Timothy P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
7:21 PM		BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2025
12:54 PM		BioMarin Pharmaceutical (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/24/2025
9:26 AM		BioMarin Pharmaceutical (Subject)
Burkhart Erin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/19/2025
3:07 PM		BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2025
1:14 PM		BioMarin Pharmaceutical (Subject)
Capital Research Global Investors (Filed by)
Form SCHEDULE 13G/A
12/03/2024
5:15 PM		BioMarin Pharmaceutical (Issuer)
Hardy Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
1:44 PM		BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
1:27 PM		BioMarin Pharmaceutical (Subject)
Guyer Charles Greg (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/31/2024
2:01 PM		BioMarin Pharmaceutical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/01/2024
3:50 PM		BioMarin Pharmaceutical (Issuer)
Friberg Gregory R (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
Banks aren’t ready for this altcoin—are you? (Ad)

Want to see why we believe this could be the next evolution of financial infrastructure? The old financial system is showing cracks—and this altcoin might be ready to take its place

Click here to discover our top crypto pick for the market right now.
10/01/2024
3:51 PM		BioMarin Pharmaceutical (Issuer)
Friberg Gregory R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
3:29 PM		BioMarin Pharmaceutical (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
Form SC 13G
09/24/2024
7:31 AM		BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2024
4:54 PM		BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
11:52 AM		BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/28/2024
4:02 PM		BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2024
4:00 PM		BioMarin Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
10:48 AM		BioMarin Pharmaceutical (Subject)
Burkhart Erin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/10/2024
12:14 PM		BioMarin Pharmaceutical (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:BMRN) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsored
Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...
Paradigm Press | Sponsored
379 passengers walked away from this
Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists
True Market Insiders | Sponsored
Israel-Iran WAR Could Destroy Trump's Presidency
The missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...
American Alternative | Sponsored
Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...
Brownstone Research | Sponsored
The $7 company helping Nvidia build the world’s first trillion-dollar robot …
Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...
Weiss Ratings | Sponsored
Crypto Is Pumping Again – Now Comes the Real Opportunity
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored